Aeglea BioTherapeutics, Inc. (21) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Form of Securities Purchase Agreement, dated as of May 5, 2022, by and among Aeglea BioTherapeutics, Inc. and the purchasers identified therein
(Filed With SEC on May 6, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on May 6, 2022)
-
Registration Rights Agreement, dated March 16, 2021, by and among the Registrant and Baker Brothers Life Sciences, L.P. and 667, L.P
(Filed With SEC on March 18, 2021)
-
Underwriting Agreement dated April 28, 2020
(Filed With SEC on April 28, 2020)
-
Amendment #1, dated December 4, 2018, to Amendment and Restated Investors' Rights Agreement, as amended
(Filed With SEC on March 7, 2019)
-
2016 Employee Stock Purchase Plan and forms of award agreements, as amended
(Filed With SEC on March 7, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on April 28, 2020)
-
Underwriting Agreement dated February 5, 2019, as amended
(Filed With SEC on February 7, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on February 7, 2019)
